Sari, M. 2020. Extra-abdominal aggressive fibromatosis treated with meloxicam and sorafenib: An encouraging option. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , vol.16, no.4 , 900-902.

Sari, M., (2020). Extra-abdominal aggressive fibromatosis treated with meloxicam and sorafenib: An encouraging option. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , vol.16, no.4, 900-902.

Sari, Murat. "Extra-abdominal aggressive fibromatosis treated with meloxicam and sorafenib: An encouraging option," JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , vol.16, no.4, 900-902, 2020

Sari, Murat. "Extra-abdominal aggressive fibromatosis treated with meloxicam and sorafenib: An encouraging option." JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , vol.16, no.4, pp.900-902, 2020

Sari, M. (2020) . "Extra-abdominal aggressive fibromatosis treated with meloxicam and sorafenib: An encouraging option." JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , vol.16, no.4, pp.900-902.

@article{article, author={Murat Sari}, title={Extra-abdominal aggressive fibromatosis treated with meloxicam and sorafenib: An encouraging option}, journal={JOURNAL OF CANCER RESEARCH AND THERAPEUTICS}, year=2020, pages={900-902} }